Literature DB >> 19926489

Insights into the genetic basis and immunopathogenesis of systemic lupus erythematosus from the study of mouse models.

Yui-Ho Cheung1, Christina Loh, Evelyn Pau, Julie Kim, Joan Wither.   

Abstract

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by production of autoantibodies directed against nuclear antigens resulting in formation of immune complexes that deposit in multiple organs causing tissue damage. SLE is a complex genetic disease in which variations in multiple genes, each with a modest effect size, contribute to disease genesis. Given this genetic complexity, identification of the role of individual polymorphisms is challenging. In this context, studies of mouse models of lupus have been particularly informative. Here we review the findings arising from the study of gene deleted, transgenic and congenic lupus-prone mouse models.

Entities:  

Mesh:

Year:  2009        PMID: 19926489     DOI: 10.1016/j.smim.2009.10.005

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  11 in total

Review 1.  T cells, murine chronic graft-versus-host disease and autoimmunity.

Authors:  Robert A Eisenberg; Charles S Via
Journal:  J Autoimmun       Date:  2012-06-16       Impact factor: 7.094

2.  Unravelling the pathogenesis of lupus nephritis: novel genetic study confirms decisive contribution of circulating colony-stimulating factor-1 (CSF-1).

Authors:  Thomas Rauen; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2010-03-18       Impact factor: 2.370

3.  Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage.

Authors:  Lino L Teichmann; Michelle L Ols; Michael Kashgarian; Boris Reizis; Daniel H Kaplan; Mark J Shlomchik
Journal:  Immunity       Date:  2010-12-14       Impact factor: 31.745

4.  Association of BLK (rs13277113, rs2248932) polymorphism with systemic lupus erythematosus: a meta-analysis.

Authors:  Ye Fan; Jin-Hui Tao; Li-Ping Zhang; Lian-Hong Li; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2010-12-09       Impact factor: 2.316

Review 5.  Fueling autoimmunity: type I interferon in autoimmune diseases.

Authors:  Jeremy Di Domizio; Wei Cao
Journal:  Expert Rev Clin Immunol       Date:  2013-03       Impact factor: 4.473

Review 6.  Humanized Mouse Models of Systemic Lupus Erythematosus: Opportunities and Challenges.

Authors:  Jiaxuan Chen; Shuzhen Liao; Huimin Zhou; Lawei Yang; Fengbiao Guo; Shuxian Chen; Aifen Li; Quanren Pan; Chen Yang; Hua-Feng Liu; Qingjun Pan
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

Review 7.  Treatment targets in systemic lupus erythematosus: biology and clinical perspective.

Authors:  Valentin Marian; Jennifer H Anolik
Journal:  Arthritis Res Ther       Date:  2012-11-30       Impact factor: 5.156

8.  The effect of esculentoside A on lupus nephritis-prone BXSB mice.

Authors:  Hualin Ma; Xianggui Zhang; Xinzhou Zhang; Dan Yang; Lingguo Meng; Yi Zhang; Shuyan Zhou
Journal:  Arch Med Sci       Date:  2012-10-30       Impact factor: 3.318

9.  TLR tolerance reduces IFN-alpha production despite plasmacytoid dendritic cell expansion and anti-nuclear antibodies in NZB bicongenic mice.

Authors:  Evelyn Pau; Yui-Ho Cheung; Christina Loh; Ginette Lajoie; Joan E Wither
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

Review 10.  Targeting the B-cell pathway in lupus nephritis: current evidence and future perspectives.

Authors:  Panagiotis Pateinakis; Athina Pyrpasopoulou
Journal:  ScientificWorldJournal       Date:  2013-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.